IL6 and breast carcinoma: Specifically, IL-6, IL-11, their receptors and downstream transcription factor STAT3, are known to be highly expressed in breast cancer (Figure 1), and the role of cytokine-induced STAT3 signaling in the breast tumor microenvironment is multifaceted [4].